Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5801
PUT
Wabtec
WAB
$49.3B
| $281K | ﹤0.01% |
+3,600
| New | +$297K |
2017 Q1
0 quarters
|
|
5802
Werner Enterprises
WERN
$2.05B
| $281K | ﹤0.01% |
10,729
-27,709
| -72% | -$755K |
2016 Q4
1 quarter
|
|
|
VXZ
5803
CALL
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
| $281K | ﹤0.01% |
10,700
-18,100
| -63% | -$538K |
2016 Q3
2 quarters
|
|
|
DRYS
5804
DELISTED
DryShips Inc. Common Stock
DRYS
| $281K | ﹤0.01% |
+174
| New | +$1.02M |
2017 Q1
0 quarters
|
|
|
GTLS
5805
CALL
DELISTED
Chart Industries
GTLS
| $280K | ﹤0.01% |
8,000
-7,900
| -50% | -$292K |
2013 Q4
13 quarters
|
|
5806
CALL
iShares Europe ETF
IEV
$1.59B
| $280K | ﹤0.01% |
6,700
-1,400
| -17% | -$56.5K |
2016 Q3
2 quarters
|
|
|
CBPO
5807
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $280K | ﹤0.01% |
2,800
+600
| +27% | +$64.1K |
2016 Q3
2 quarters
|
|
5808
Bright Horizons
BFAM
$3.12B
| $279K | ﹤0.01% |
+3,849
| New | +$270K |
2017 Q1
0 quarters
|
|
5809
CALL
Enovis
ENOV
$1.08B
| $279K | ﹤0.01% |
4,125
-7,902
| -66% | -$527K |
2013 Q2
15 quarters
|
|
5810
CALL
Etsy
ETSY
$6.51B
| $279K | ﹤0.01% |
26,200
+13,600
| +108% | +$159K |
2016 Q4
1 quarter
|
|
5811
PUT
Evolent Health
EVH
$408M
| $279K | ﹤0.01% |
+12,500
| New | +$240K |
2017 Q1
0 quarters
|
|
5812
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1.03B
| $279K | ﹤0.01% |
+18,848
| New | +$287K |
2017 Q1
0 quarters
|
|
5813
Sanmina
SANM
$12.1B
| $279K | ﹤0.01% |
+6,873
| New | +$266K |
2017 Q1
0 quarters
|
|
5814
PUT
Travere Therapeutics
TVTX
$5.44B
| $279K | ﹤0.01% |
15,100
+3,200
| +27% | +$62.6K |
2014 Q3
10 quarters
|
|
|
INFI
5815
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $279K | ﹤0.01% |
86,522
+70,678
| +446% | +$174K |
2016 Q3
2 quarters
|
|
|
DPLO
5816
PUT
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $279K | ﹤0.01% |
+17,500
| New | +$252K |
2017 Q1
0 quarters
|
|
5817
PUT
First Horizon
FHN
$11.1B
| $278K | ﹤0.01% |
+15,000
| New | +$295K |
2017 Q1
0 quarters
|
|
5818
Mercer International
MERC
$16.6M
| $278K | ﹤0.01% |
+23,727
| New | +$279K |
2017 Q1
0 quarters
|
|
5819
CALL
Steris
STE
$20.6B
| $278K | ﹤0.01% |
4,000
-100
| -2% | -$6.92K |
2016 Q4
1 quarter
|
|
|
INVX
5820
CALL
Innovex International
INVX
$1.99B
| $278K | ﹤0.01% |
+5,100
| New | +$305K |
2017 Q1
0 quarters
|
|
|
INVX
5821
PUT
Innovex International
INVX
$1.99B
| $278K | ﹤0.01% |
+5,100
| New | +$305K |
2017 Q1
0 quarters
|
|
5822
CALL
ProShares UltraShort Russell2000
TWM
$64M
| $277K | ﹤0.01% |
+620
| New | +$285K |
2017 Q1
0 quarters
|
|
|
MDC
5823
DELISTED
M.D.C. Holdings, Inc.
MDC
| $277K | ﹤0.01% |
11,621
-73,669
| -86% | -$1.66M |
2016 Q1
4 quarters
|
|
|
SPNC
5824
CALL
DELISTED
Spectranetics Corp
SPNC
| $277K | ﹤0.01% |
9,500
-2,300
| -19% | -$61.3K |
2016 Q2
3 quarters
|
|
5825
PUT
Republic Services
RSG
$65.2B
| $276K | ﹤0.01% |
4,400
-2,500
| -36% | -$150K |
2013 Q2
15 quarters
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.